Clinical Development of Today
Increasing the value of early phase study data while reducing study cost and time is a continuous challenge in drug development. Adaptive design, modelling and simulation, exposure/repsonse relationships, real word data analysis, patient reported outcomes, technology and modern regulatory guidances have all paved the way to allow for efficiencies in precision, time and cost for clinical development.
Now, more than ever, early clinical development can generate information that provides a greater understanding of a therapies potential. Doing so increases the value of the therapy to external stakeholders, paves the way for a abbreviated path to market and provides confidence in decision making when entering costly later phase studies. Armstrong Clinical is designed to provide biotech companies access to traditional and modern strategies used to maximise precision, value and speed to market.